). An intent-to-treat analysis similarly showed that the cure rate with metronidazole was superior to triple-sulfa (P-< 0.02). The clinical diagnosis demonstrated a high correlation (88%) with the diagnosis made by an independent assessment by Gram's stain. The side effects reported by the patients using metronidazole gel were infrequent and mild and were similar to those reported with triple-sulfa.
rates are high at both short-term (7-14 days) (75-90%) and long-term (28-30 days) (60-80%) followtlp. 4'8'9 The relatively few limitations in the use of oral metronidazole include concern about its use in the first trimester of pregnancy and allergy and gastrointestinal side effects. 1 Nugent et al. 8 The evaluations for efficacy and safety were made at visit 2 scheduled for 12-16 days and visit 3 scheduled for 28-35 days after completion of therapy.
Statistical Analysis
The Cochran-Mantel-Haenszel statistical procedure and Fisher's exact test were used for comparisons in the data analysis.
RESULTS
A total of 247 subjects were enrolled by 10 The overall success rate for topical metronidazole in this study was 5-10% lower than that observed in other trials using topical metronidazole gel. 8, 6 These differences however, may be attributed to variability in the population or vaginitis severity that frequently exists among trials as well as to variability in the criteria for defining cure rather than to any true difference in the efficacy of metronidazole gel. In the current study, 60% of the patients had previously been treated for BV. In addition, 40% of the evaluable patients were enrolled by 2 investigators (J.D.S., J.T.) with clinical practices serving patients with chronic or intractable vaginitis. 
